172@29@17@105!~!172@29@0@53!~!|news|india|coronavirus-wrap-august-13-ram-temple-trust-head-tests-positive-study-finds-6-of-england-infected-by-covid-19-5697501.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Aug 13, 2020 09:52 PM IST | Source: Moneycontrol.com

Coronavirus wrap August 13 | Ram Temple trust head tests positive; study finds 6% of England infected by COVID-19

Globally, more than 2.05 crore infections and over 7.44 lakh deaths have been reported due to the COVID-19 outbreak.

India has recorded more than 23.9 lakh cases of the novel coronavirus and 47,033 deaths, according to the Union health ministry's latest update. Of these, more than 6.53 lakh are active cases while nearly 17 lakh have recovered.

Maharashtra reported the highest number of infections, followed by Tamil Nadu and Andhra Pradesh.

Close

Globally, more than 2.05 crore infections and over 7.44 lakh deaths have been reported due to the COVID-19 outbreak.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Here are all the latest updates:

>> India reported the highest single-day spike in COVID-19 cases with 66,999 new cases and 942 deaths. The recovery rate rose to 70.77 percent while the fatality rate declined to 1.96 percent, the Union health ministry said.

>> A major antibody test study found 6 percent of England infected by COVID-19.

>> Chief of the Ram temple trust Mahant Nritya Gopal Das tested positive for COVID-19. He had shared stage with Prime Minister Narendra Modi on August 5.

>> A tuberculosis vaccination has been linked with significantly improved COVID-19 outcomes, a study by Ben-Gurion University of the Negev and Hebrew University of Jerusalem in Israel stated.

>> Drug firm Zydus Cadila launched COVID-19 drug Remdesivir in India.

>> The Centre said a single system will be set up to procure COVID-19 vaccines for requirements across India.
First Published on Aug 13, 2020 08:31 pm
Sections